HealthMore in Health→
Experimental once-daily antiviral shows promise against measles and parainfluenza
A Georgia State-led team reports that an oral drug candidate, GHP-88310, suppressed orthoparamyxovirus infections in animal models, offering a potential route toward treatments for measles, croup-linked viruses and other
Key Takeaways
- Researchers identified oral clinical candidate GHP-88310 for orthoparamyxovirus infections.
- The study reports efficacy in rodent and non-rodent animal models.
DE
DT Editorial Team··via medicalxpress.com